OGN

Organon Stock Analysis

AI Rating

Low
  • Quality5/10
  • Growth 0/10
  • Value 8/10
Organon sales and earnings growth
OGN Growth
Low
  • Revenue Y/Y -2.92%
  • EPS Y/Y -78.57%
  • FCF Y/Y -29.82%
Organon gross and profit margin trends
OGN Profitability
Neutral
  • Gross margin 53.30%
  • EPS margin 3.00%
  • ROIC 5Y 10.12%
Organon recent dividend growth
OGN Dividends
  • Dividend yield 1.28%
  • Growth 3Y -44.90%
  • Payout ratio 47%
Organon net debt vs free cash flow
OGN Risk
Poor
  • Debt / Equity 11.5
  • Debt / FCF 15.0
  • Interest coverage 1.8

Organon stock is less volatile than the overall market, so it's low risk. We give it a Poor risk rating.

More Drug Manufacturers - General stocks ↗